KALA BIO
KALA
22 hedge funds and large institutions have $2.69M invested in KALA BIO in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 9 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0.63% less ownership
Funds ownership: 1.13% → 0.5% (-0.63%)
19% less funds holding
Funds holding: 27 → 22 (-5)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
84% less capital invested
Capital invested by funds: $17.3M → $2.69M (-$14.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$401K |
| 2 |
State Street
Boston,
Massachusetts
|
+$284K |
| 3 |
MG
Marex Group
London,
|
+$144K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$115K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$80.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.87M |
| 2 |
SOCM
SR One Capital Management
Wayne,
Pennsylvania
|
-$2.85M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$2.15M |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.43M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$660K |
KALA Hedge Fund Activity: Q3 2025 in Review
22 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2025, worth a combined $2.69M — down 84% from $17.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of KALA and 5 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $401K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.87M sold.
- 22 institutional investors held KALA BIO (KALA) as of Q3 2025, down from 27 in Q2 2025.
- Funds reported $2.69M of KALA BIO stock for Q3 2025, down 84% quarter-over-quarter.
- 5 funds opened new KALA BIO positions in Q3 2025 and 9 closed out, a net change of -4 holders.
- The largest KALA BIO buyer in Q3 2025 was Vanguard Group, an estimated $401K added.
- The largest KALA BIO seller in Q3 2025 was Cormorant Asset Management, an estimated $2.87M sold.
Based on aggregated 13F filings for Q3 2025.